
Global & Denmark Cancer Therapeutics Market to 2031
Description
Cancer is the leading cause of death in Denmark, according to the Danish Cancer Society. Statistics show that one in three Danes will be diagnosed with cancer before reaching the age of 75, and two out of three individuals have a close family member affected by the disease. Projections indicate that between 2023 and 2050, cancer will account for 30% of all premature deaths (those occurring before age 75), translating to an estimated 5,100 early cancer-related fatalities each year. This growing burden underscores the urgent need for effective cancer therapies in the country.
The Danish Cancer Society manages the nation's largest center for cancer prevention and knowledge dissemination. Its core mission is to reduce cancer incidence, improve recovery rates, and lessen the physical, mental, and social challenges faced by patients. In addition to funding cancer research at hospitals and universities throughout Denmark, the organization also operates its own research facility, the Danish Cancer Institute (DCI).
The Danish government has played a pivotal role in advancing cancer treatment by supporting research initiatives and encouraging collaboration across academic, healthcare, and private sectors. In November 2023, the government announced an additional allocation of US$ 44.19 million (300 million DKK) to reinforce cancer care services in 2024. Furthermore, starting in 2025, a recurring annual investment of US$ 88.39 million (600 million DKK) will be dedicated to the national cancer plan. These sustained funding efforts position Denmark as a leader in cancer care innovation, with a focus on lowering cancer rates and improving outcomes for patients.
The Danish Cancer Society manages the nation's largest center for cancer prevention and knowledge dissemination. Its core mission is to reduce cancer incidence, improve recovery rates, and lessen the physical, mental, and social challenges faced by patients. In addition to funding cancer research at hospitals and universities throughout Denmark, the organization also operates its own research facility, the Danish Cancer Institute (DCI).
The Danish government has played a pivotal role in advancing cancer treatment by supporting research initiatives and encouraging collaboration across academic, healthcare, and private sectors. In November 2023, the government announced an additional allocation of US$ 44.19 million (300 million DKK) to reinforce cancer care services in 2024. Furthermore, starting in 2025, a recurring annual investment of US$ 88.39 million (600 million DKK) will be dedicated to the national cancer plan. These sustained funding efforts position Denmark as a leader in cancer care innovation, with a focus on lowering cancer rates and improving outcomes for patients.
Table of Contents
100 Pages
- 1. Introduction
- 1.1 Report Guidance
- 1.2 Market Segmentation
- 2. Executive Summary
- 2.1 Key Insights
- 3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Data Triangulation and Validation:
- 4. Denmark Cancer Therapeutics Market Landscape
- 4.1 Overview
- 4.2 Ecosystem Analysis
- 4.2.1 List of Vendors in the Value Chain
- 5. Cancer Therapeutics Market Key Market Dynamics
- 5.1 Cancer Therapeutics Market – Key Market Dynamics
- 5.2 Market Drivers
- 5.3 Market Restraints
- 5.4 Market Opportunities
- 5.5 Future Trends
- 5.6 Impact of Drivers and Restraints
- 6. Denmark Cancer Therapeutics Market – Analysis
- 6.1 Denmark Cancer Therapeutics Market Revenue (US$ Million), 2021–2031
- 6.2 Denmark Cancer Therapeutics Market Revenue and Forecast Analysis
- 7. Denmark Cancer Therapeutics Market Analysis – by Therapy Types
- 7.1 Denmark Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Therapy Types
- 8. Denmark Cancer Therapeutics Market Analysis – by Indications
- 8.1 Denmark Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Indications
- 9. Denmark Cancer Therapeutics Market Analysis – by Distribution Channel
- 9.1 Denmark Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Distribution Channel
- 10. Competitive Landscape
- 10.1 Heat Map Analysis by Key Players
- 10.1 Company Positioning and Concentration
- 11. Industry Landscape
- 11.1 Overview
- 11.2 Market Initiative
- 11.2 Partnerships and Collaborations
- 11.2 Other Developments
- 12. Company Profiles
- 12.1 Bristol-Myers Squibb Co
- 12.1. 1 Key Facts
- 12.1. 2 Business Description
- 12.1. 3 Products and Services
- 12.1. 4 Financial Overview
- 12.1. 5 SWOT Analysis
- 12.1. 6 Key Developments
- 12.2 AbbVie Inc
- 12.2. 1 Key Facts
- 12.2. 2 Business Description
- 12.2. 3 Products and Services
- 12.2. 4 Financial Overview
- 12.2. 5 SWOT Analysis
- 12.2. 6 Key Developments
- 12.3 Johnson & Johnson
- 12.3. 1 Key Facts
- 12.3. 2 Business Description
- 12.3. 3 Products and Services
- 12.3. 4 Financial Overview
- 12.3. 5 SWOT Analysis
- 12.3. 6 Key Developments
- 12.4 F. Hoffmann-La Roche Ltd
- 12.4. 1 Key Facts
- 12.4. 2 Business Description
- 12.4. 3 Products and Services
- 12.4. 4 Financial Overview
- 12.4. 5 SWOT Analysis
- 12.4. 6 Key Developments
- 12.5 Pfizer Inc
- 12.5. 1 Key Facts
- 12.5. 2 Business Description
- 12.5. 3 Products and Services
- 12.5. 4 Financial Overview
- 12.5. 5 SWOT Analysis
- 12.5. 6 Key Developments
- 12.6 AstraZeneca Plc
- 12.6. 1 Key Facts
- 12.6. 2 Business Description
- 12.6. 3 Products and Services
- 12.6. 4 Financial Overview
- 12.6. 5 SWOT Analysis
- 12.6. 6 Key Developments
- 12.7 Merck KGaA
- 12.7. 1 Key Facts
- 12.7. 2 Business Description
- 12.7. 3 Products and Services
- 12.7. 4 Financial Overview
- 12.7. 5 SWOT Analysis
- 12.7. 6 Key Developments
- 12.8 Novartis AG
- 12.8. 1 Key Facts
- 12.8. 2 Business Description
- 12.8. 3 Products and Services
- 12.8. 4 Financial Overview
- 12.8. 5 SWOT Analysis
- 12.8. 6 Key Developments
- 12.9 Astellas Pharma Inc
- 12.9. 1 Key Facts
- 12.9. 2 Business Description
- 12.9. 3 Products and Services
- 12.9. 4 Financial Overview
- 12.9. 5 SWOT Analysis
- 12.9. 6 Key Developments
- 12.10 Eli Lilly and Co
- 12.10. 1 Key Facts
- 12.10. 2 Business Description
- 12.10. 3 Products and Services
- 12.10. 4 Financial Overview
- 12.10. 5 SWOT Analysis
- 12.10. 6 Key Developments
- 13. Appendix
- 13.1 About Business Market Insights
- 13.2 List of Abbreviations
- TABLE OF TABLES
- Table 1. Denmark Cancer Therapeutics Market Segmentation
- Table 2. List of Vendors
- Table 3. Denmark Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million)
- Table 4. Denmark Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million)
- Table 5. Denmark Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Therapy Types
- Table 6. Denmark Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy Types
- Table 7. Denmark Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Indications
- Table 8. Denmark Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
- Table 9. Denmark Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel
- Table 10. Denmark Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel
- Table 11. List of Abbreviations
- TABLE OF FIGURES
- Figure 1. Impact Analysis of Drivers and Restraints
- Figure 2. Denmark Cancer Therapeutics Market Revenue, (US$ Million), 2021–2031
- Figure 3. Heat Map Analysis by Key Players
- Figure 4. Company Positioning and Concentration
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.